TERUMO CORP (TUO BE) stock market data APIs
€12.0978
0(0%)
as of February 18, 2026
Try our APIs with
free plan!
TERUMO CORP Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for TUO.BE.
Prev. Close
12.0978
Open
12.0978
High
12.0978
Low
12.0978
52 wk Range
12-17.1922
Market Cap
27 604 M
Dividends (Yield)
0.4516
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get TERUMO CORP data using free add-ons & libraries
Get TERUMO CORP Fundamental Data
TERUMO CORP Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-13
- EPS/Forecast: 21.5
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
TERUMO CORP News
New
Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
Q-Sera Pty Ltd MELBOURNE, Australia , Feb. 19, 2026 (GLOBE NEWSWIRE) -- Q-Sera Pty Ltd, an Australian venture-backed company, today announced the first product launch of its patented evacuated blood ...
Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology
- New, retractable safety hypodermic line offers enhanced safety, reliability and ease of use while minimizing patient discomfort* - SOMERSET, N.J., Jan. 6, 2026 /PRNewswire/ -- Terumo Medical Corpor...
Santersus AG Completes Series A Financing and Announces Strategic Collaboration with Terumo Corporation
Santersus AG Announces Advancement of NucleoCapture into Pivotal Clinical Development strengthened by Strategic Collaboration with Terumo ZURICH, SWITZERLAND / ACCESS Newswire / December 1, 2025 / Sa...
Terumo (TSE:4543): Evaluating Value After Prolonged Share Price Decline
Terumo (TSE:4543) has recently caught the attention of investors following a sustained share price decline over the past month, with the stock down nearly 5% and extending to a 14% drop over the past ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
